Who is sponsoring NCT05473650?

NCT05473650 is sponsored by Assiut University.

What drugs are being tested in NCT05473650?

Interventions in NCT05473650: CBC.with with differential Peripheral smear.

What condition does NCT05473650 study?

NCT05473650 studies Pancytopenia.

Is NCT05473650 still recruiting?

NCT05473650 is currently status unknown. Last updated 26 July 2022.

Last reviewed 2022-07-26 · How we verify

NCT05473650

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spectrum of Hematological Disorders in Pediatrics

Status unknown Last updated 26 July 2022

What this trial tests

trial testing CBC.with with differential Peripheral smear in Pancytopenia in 100 participants. Status unknown.

Timeline

1 September 2022

Primary endpoint
30 September 2023

1 November 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2022
Primary completion	30 September 2023
Estimated completion	1 November 2023

Drugs / interventions tested

CBC.with with differential Peripheral smear

Conditions studied

Pancytopenia — all drugs for Pancytopenia →

Sponsor

Assiut University

Who can join

Adults 28 Days to 18, any sex, with Pancytopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the spectrum of pancytopenia with its frequency and etiology in children presenting to Assiut University Children Hospital during one year

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05473650 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 26 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05473650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing